ACRV - CIK 0001781174
Acrivon Therapeutics, Inc. has filed 321 documents with the SEC between 2021 and 2026. The most frequent type is insider trade (166 filings), alongside the regular cadence of annual reports, quarterly reports, and event disclosures every public company must make. Use the filters to focus on one filing type, or flip the sort to trace the company's history from its earliest paperwork.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Filing | Type | Filed | Period covered |
|---|---|---|---|
| Quarterly report | 10-Q | 2023-05-09 | 2023-03-31 |
| Major company event | 8-K | 2023-05-01 | 2023-05-01 |
| Major company event | 8-K | 2023-05-01 | 2023-05-01 |
| Annual report to shareholders | ARS | 2023-05-01 | 2022-12-31 |
| Proxy materials | DEFA14A | 2023-05-01 | - |
| Proxy statement | DEF 14A | 2023-05-01 | 2023-06-22 |
| Major company event | 8-K | 2023-04-25 | 2023-04-25 |
| Activist ownership stake (update) | SC 13D/A | 2023-03-30 | - |
| Employee stock plan | S-8 | 2023-03-29 | - |
| Major company event | 8-K | 2023-03-28 | 2023-03-28 |
| Annual report | 10-K | 2023-03-28 | 2022-12-31 |
| Major company event | 8-K | 2023-03-13 | 2023-03-13 |
| Major company event | 8-K | 2023-03-03 | 2023-03-03 |
| Passive ownership stake (update) | SC 13G/A | 2023-02-14 | - |
| Passive ownership stake (update) | SC 13G/A | 2023-02-14 | - |
| Passive ownership stake (update) | SC 13G/A | 2023-02-14 | - |
| Passive ownership stake | SC 13G | 2023-02-14 | - |
| Quarterly report | 10-Q | 2022-12-15 | 2022-09-30 |
| Passive ownership stake | SC 13G | 2022-11-28 | - |
| Activist ownership stake | SC 13D | 2022-11-28 | - |
| Passive ownership stake | SC 13G | 2022-11-25 | - |
| Insider trade | 4 | 2022-11-21 | 2022-11-17 |
| Insider trade | 4 | 2022-11-21 | 2022-11-17 |
| Passive ownership stake | SC 13G | 2022-11-21 | - |
| Insider trade | 4 | 2022-11-21 | 2022-11-17 |
| Passive ownership stake | SC 13G | 2022-11-18 | - |
| New insider ownership | 3 | 2022-11-18 | 2022-11-17 |
| Major company event | 8-K | 2022-11-17 | 2022-11-14 |
| Employee stock plan | S-8 | 2022-11-17 | - |
| Insider trade | 4 | 2022-11-16 | 2022-11-14 |
| Insider trade | 4 | 2022-11-16 | 2022-11-14 |
| Insider trade | 4 | 2022-11-16 | 2022-11-14 |
| Insider trade | 4 | 2022-11-16 | 2022-11-14 |
| Insider trade | 4 | 2022-11-16 | 2022-11-14 |
| Insider trade | 4 | 2022-11-16 | 2022-11-14 |
| Insider trade | 4 | 2022-11-16 | 2022-11-14 |
| Insider trade | 4 | 2022-11-16 | 2022-11-14 |
| 424B4 | - | 2022-11-16 | - |
| Insider trade | 4 | 2022-11-16 | 2022-11-14 |
| 3/A | - | 2022-11-14 | 2022-11-09 |
| S-1MEF | - | 2022-11-14 | - |
| Free writing prospectus | FWP | 2022-11-14 | - |
| SEC STAFF LETTER | - | 2022-11-09 | - |
| EFFECT | - | 2022-11-09 | - |
| New insider ownership | 3 | 2022-11-09 | 2022-11-09 |
| New insider ownership | 3 | 2022-11-09 | 2022-11-09 |
| New insider ownership | 3 | 2022-11-09 | 2022-11-09 |
| New insider ownership | 3 | 2022-11-09 | 2022-11-09 |
| New insider ownership | 3 | 2022-11-09 | 2022-11-09 |
| New insider ownership | 3 | 2022-11-09 | 2022-11-09 |